Lung targeted delivery of Everolimus as a new treatment of Scleroderma-relatedinterstitial lung disease (SSC-ILD) developed by PSGL-1 KO mice

  1. Elena González Sánchez
  2. J Gómez Román
  3. Antonio Muñoz Callejas
  4. A Marengo
  5. N Tsapis
  6. K Bohne Japiassu
  7. M.Á. González Gay
  8. Esther Vicente Rabaneda
  9. E. Fattal
  10. Santos Castañeda
  11. Ana Urzainqui
Actas:
Annual European Congress of Rheumatology EULAR 2021

Editorial: European Alliance of Associations for Rheumatology

Año de publicación: 2021

Tipo: Aportación congreso